Information Provided By: 
Fly News Breaks for September 11, 2019
PFNX
Sep 11, 2019 | 06:11 EDT
JMP Securities analyst Jason Butler raised his price target on Pfenex to $17 and kept his Outperform rating, saying its platform potential is becoming increasingly "visible and validated". The analyst cites the company's lead candidate PF708 progressing toward approval, with a possible Q4 commercial launch. Butler notes that Pfenex now has the opportunity for increased focus on additional pipeline programs such as PF743/PF745 and CRM197, which have "already demonstrated value."
News For PFNX From the Last 2 Days
There are no results for your query PFNX
